Superworth

Waters PE ratio WAT

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Oct 23, 2026
113×
10-year median
29.2×
Against its 10-year history
94th
percentile: 0 is its lowest day, 100 its highest
10-year range
19.8× to 312×
Peer median
38.4×

Waters' PE ratio is 113× as of Oct 23, 2026: a share price of $453.67 against $4.01 of earnings per share over the last twelve months.

That is above its ten-year median of 29.2×, higher than on 94% of days in the last ten years.

Over that time it ranged from 19.8× in Mar 2020 to 312× in Sep 2018.

The median for 10 diagnostics and research stocks of a similar size is 38.4×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far113×26.6×113×
202535.5×25.4×39.6×
202435.7×27.3×36.9×
202329.9×21.6×29.9×
202229.9×23.5×31.8×
202133.4×29.7×40.0×
202031.0×19.8×31.3×
201928.8×25.8×306×
2018240×28.6×312×
201728.5×23.0×30.2×
201622.1×20.5×28.1×
201523.9×21.1×25.2×
201423.1×17.6×23.5×
201317.9×16.6×19.8×
201218.4×16.1×19.8×
201116.3×15.8×24.1×
201020.5×17.5×21.2×

Against its peers

Companies in Medical - Diagnostics & Research nearest Waters' size, closest first, today.

CompanyPE ratio
WATWaters113×
IDXXIDEXX Laboratories39.4×
IQVIQVIA34.7×
AAgilent Technologies34.0×
ILMNIllumina50.1×
MTDMettler-Toledo International37.6×
DGXQuest Diagnostics25.7×
LHLabcorp27.2×
MEDPMedpace39.2×
RVTYRevvity75.6×
DHRDanaher40.9×
Peer median38.4×

Where Waters ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Waters

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.